Spectral AI, Inc. (MDAI) Regains Nasdaq Compliance

Go back to Spectral AI, Inc. (MDAI) Regains Nasdaq Compliance

Spectral AI Announces Confirmation of Compliance of its Nasdaq Listing Requirements

December 23, 2024 8:00 AM EST

DALLAS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (Spectral AI or the Company), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. FDA in 2018, that uses multi-spectral imaging and algorithms to predict burn healing potential, is pleased to announce that on December 20, 2024 the Company received a moot letter from Nasdaq confirming that the Company has regained compliance with all applicable listing standards for its continued listing on the Nasdaq Capital Market and that a further hearing regarding the Companys compliance is no... More